Enjoy complimentary customisation on priority with our Enterprise License!
The Global Scar Treatment Market size is estimated to grow by USD 13,170.76 million at a CAGR of 9.07% between 2022 and 2027.
There is an increasing demand for non-invasive scar treatment procedures among customers. Non-evasive procedures can be referred to as techniques that include the smallest of surgical incisions. These techniques are widely used to minimize the pain and scarring related to open surgical procedures, allow quick recoveries, and minimize the chances of post-surgical complications, such as adhesions and wound dehiscence. There is an increasing popularity of minimally invasive and non-invasive scar treatment procedures among customers over the years. The main advantage of this non-invasive scar treatment procedure is the minimal downtime when compared to normal surgical procedures. Hence, such factors are positively impacting the market growth.
Technavio has segmented the market into Product, Type, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The topical segment is estimated to witness significant growth during the forecast period. Topical scar treatment products comprise lotions, gels, ointments, and even sheets that help reduce the appearance of scars. The main purpose of these products is to heal the top layers of the skin. Some solutions achieve this by gently scraping away the upper-most skin cells that have the scar whereas others depend on hydration to fill the skin and make it look less discolored or deformed.
Get a glance at the market contribution of various segments View a PDF Sample
The topical segment was the largest segment and was valued at USD 11,433.33 million in 2017. Several market players in the global scar treatment market offer topical scar management topical products. For example, Sientra is one of the prominent market players in the global scar treatment market offering BIOCORNEUM, a scar management product for use by plastic surgeons, dermatologists, and other medical specialists. These products are widely available on e-commerce platforms such as Amazon.com Inc. (Amazon). Additionally, there has been significant growth in the online platforms for topical drugs used for scar treatment. The increasing preference for these online platforms by consumers is due to the convenience, accessibility, and wide range of options to consumers. Also, the online platform offers a detailed description of drugs to consumers such as the ingredients, dosage, and possible side effects. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
The atrophic scar can be referred to as an indented scar that heals below the upper-most layer of skin tissue. These types of scars develop when the skin is unable to repair the tissue. As a result, it leads to uneven scarring. Some of the common types of atrophic scars are chickenpox or severe acne scars. These kinds of scars are difficult to treat and need multiple procedures which are required to be repeated over a period of time. Chemical peels and injectables are some of the scar treatments for atrophic scars. There is increasing popularity for chemical peels treatment which involves applying chemicals to the skin's surface, the damaged layer of the skin is removed during the peeling process. Therefore, such scar treatment options for atrophic scars are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
Hypertrophic scars are mainly formed within the site of injury and may regress over time whereas keloids spread beyond the borders of the initial injury and do not regress. Both of these scars are formed by the injury to the skin that goes deep enough to affect the dermal layer. Some of the main causes of these scars include burns, surgery, insect bites, tattoos, acne or chickenpox, and piercings. The main treatments for hypertrophic and keloid scars are medication, injections, lasers, and surgery. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Some of the main factors which are significantly contributing to the global scar treatment market in North America are the increasing awareness and adoption of non-invasive scar treatment solutions, the presence of advanced healthcare infrastructure and experienced healthcare professionals, and the wide availability of advanced diagnostic techniques in the region.
Moreover, the prominent market players in the region include Bausch Health Companies, Candela, and Sonoma Pharmaceuticals which offer innovative scar treatment solutions and are positively impacting the market growth in the region. For example, in September 2021, Sonoma Pharmaceuticals launched a new over-the-counter product, Regenacyn Advanced Scar Gel, which has been clinically proven to enhance the overall appearance of scars while reducing pain, itching, redness, and inflammation. Hence, such factors are expected to drive market growth in the region during the forecast period.
In 2020, during the COVID-19 pandemic, the growth of the global scar treatment market witnessed a significant slowdown due to the postponement of non-urgent medical procedures, including scar treatment. in North America. However, in 2021, the initiation of large-scale vaccination drives lifted the lockdown and travel restrictions, which led to the restoration of operations in healthcare units. Such factors are expected to drive the market during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Alliance Pharma PLC: The company offers scar treatment such as ScarAway silicone scar gel.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the global scar treatment market growth is the increasing beauty consciousness among consumers. There is an increasing consciousness among people regarding their physical appearance as it has become an important factor for being accepted in social situations and at the workplace. As a result, there is an increasing adoption of beautification procedures to improve their beauty and physical appearance.
Furthermore, there is an increase in the number of dual-income households in several developed countries which has increased their purchasing power. Additionally, there is increasing affordability for cosmetic surgeries in developed countries. Thus, it is positively impacting the market growth. Hence, such factors are expected to drive the global scar treatment market growth during the forecast period.
A key factor shaping the global scar treatment market growth is the rise in medical tourism. There is an increasing number of people who are traveling to developing countries for better access to healthcare services such as aesthetic medical treatment, mainly due to the availability of low-cost and high-quality treatment offered in those countries. One of the main regions in the global medical tourism industry is Asia.
Moreover, the increasing growth of medical tourism in Asia is due to the availability of advanced healthcare infrastructure and low-cost treatment. Additionally, there is a growing popularity in Asia regions globally for cosmetic surgery and aesthetic medical procedures. Thus, it is positively impacting the market growth. Hence, such factors are expected to drive market growth during the forecast period.
The high cost of scar treatment procedures is one of the key challenges hindering the market growth. There is low adoption of scar treatment procedures in developing countries due to its high cost. The average cost of laser treatment is about USD200-USD34,00 for the overall course of treatment.
Additionally, there are several factors that influence the cost of scar treatment and each patient requires the treatment which is specifically designed as per their needs. Several advancements used in scar treatment have led to the use of equipment in these procedures which has also fuelled the overall treatment cost. Hence, such factors are expected to hinder market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Scar Treatment Market Customer Landscape
The scar treatment market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Scar Treatment Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.07% |
Market growth 2023-2027 |
USD 13,170.76 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
8.42 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Alliance Pharma PLC, Avita Medical Inc., Bayer AG, Boston Scientific Corp., CCA Industries Inc., Cynosure LLC, DEKA M.E.L.A. S.r.l., Johnson and Johnson, Merz Pharma GmbH and Co KGaA, Molnlycke Health Care AB, Quantum Health, Scarguard Labs, Sientra Inc., Smith and Nephew plc, Stratpharma AG, Bausch Health Companies Inc., Candela Corp., Newmedical Technology Inc., Perrigo Co. Plc, and Sonoma Pharmaceuticals Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.